- Home
- NXTC vs SCKT Comparison
NXTC vs SCKT Comparison
Compare NXTC & SCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- SCKT
- Stock Information
- Founded
- NXTC 2015
- SCKT 1992
- Country
- NXTC United States
- SCKT United States
- Employees
- NXTC N/A
- SCKT N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- SCKT Computer Manufacturing
- Sector
- NXTC Health Care
- SCKT Technology
- Exchange
- NXTC Nasdaq
- SCKT Nasdaq
- Market Cap
- NXTC 9.3M
- SCKT 8.7M
- IPO Year
- NXTC 2019
- SCKT 1995
- Fundamental
- Price
- NXTC $0.43
- SCKT $1.26
- Analyst Decision
- NXTC Strong Buy
- SCKT
- Analyst Count
- NXTC 2
- SCKT 0
- Target Price
- NXTC $3.50
- SCKT N/A
- AVG Volume (30 Days)
- NXTC 259.7K
- SCKT 11.9K
- Earning Date
- NXTC 05-05-2025
- SCKT 04-24-2025
- Dividend Yield
- NXTC N/A
- SCKT N/A
- EPS Growth
- NXTC N/A
- SCKT N/A
- EPS
- NXTC N/A
- SCKT N/A
- Revenue
- NXTC N/A
- SCKT $18,762,520.00
- Revenue This Year
- NXTC N/A
- SCKT $8.62
- Revenue Next Year
- NXTC N/A
- SCKT N/A
- P/E Ratio
- NXTC N/A
- SCKT N/A
- Revenue Growth
- NXTC N/A
- SCKT 10.15
- 52 Week Low
- NXTC $0.22
- SCKT $0.91
- 52 Week High
- NXTC $1.82
- SCKT $1.72
- Technical
- Relative Strength Index (RSI)
- NXTC 44.58
- SCKT 63.01
- Support Level
- NXTC $0.22
- SCKT $1.06
- Resistance Level
- NXTC $0.44
- SCKT $1.31
- Average True Range (ATR)
- NXTC 0.06
- SCKT 0.07
- MACD
- NXTC 0.02
- SCKT 0.03
- Stochastic Oscillator
- NXTC 86.11
- SCKT 86.11
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
About SCKT Socket Mobile Inc.
Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, out of which the majority of the revenue is generated from the United States.